The National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,896.00 firm fixed-price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE, LAB services. The contract has an ultimate completion date of November 30, 2024 and was awarded on December 1, 2023. This award does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has provided various...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE, LAB 23-024810. The contract has a ceiling value of $14,896.00 and a period of performance ending on June 6, 2024. The contract does not have a set-aside designation. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,634.00 firm fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the provision of the Human Gene Mutation Database (HGMD) data download. Qiagen has provided various products and services to support federal agencies' biomedical research, public health, and healthcare programs...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $23,018 firm fixed price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE. The contract period is December 25, 2023 through December 24, 2024. Qiagen will provide access to and use of the Human Gene Mutation Database for research purposes under this contract. The place of performance is Qiagen's Biltmore Forest, North Carolina facility. The National Human...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., for $32,634.00. The contract provides one-year access to the Human Gene Mutation Database for clinical use at the NIH Clinical Center to support a custom bioinformatics pipeline for analyzing genomic data from patients enrolled in NIAID clinical protocols. This sole-source...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $33,646.00 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for a 1-year license to access the Human Gene Mutation Database, which provides data on approximately 200,000 human genomic mutations. This data supports NIAID's efforts to build a custom bioinformatics...
This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC, a division of Qiagen N.V. The contract, valued at $32,995.00, is to provide Ingenuity Variant Analysis software and services in support of the agency's biomedical research programs. Qiagen, a provider of sample and assay technologies, has a history of providing products and...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract has a total ceiling value of $19,008.00 and a period of performance ending on March 30, 2026. The contract does not have a set-aside designation. Qiagen, LLC will provide a range of products and services to support the NIH's biomedical research, public health, and healthcare programs, including...